Literature DB >> 22970822

Standard operating procedures for female genital sexual pain.

Kerstin S Fugl-Meyer1, Nina Bohm-Starke, Christina Damsted Petersen, Axel Fugl-Meyer, Sharon Parish, Annamaria Giraldi.   

Abstract

INTRODUCTION: Female genital sexual pain (GSP) is a common, distressing complaint in women of all ages that is underrecognized and undertreated. Definitions and terminology for female GSP are currently being debated. While some authors have suggested that GSP is not per se a sexual dysfunction, but rather a localized genial pain syndrome, others adhere to using clearly sexually related terms such as dyspareunia and vaginismus. AIM: The aims of this brief review are to present definitions of the different types of female GSP. Their etiology, incidence, prevalence, and comorbidity with somatic and psychological disorders are highlighted, and different somatic and psychological assessment and treatment modalities are discussed.
METHODS: The Standard Operating Procedures (SOP) committee was composed of a chair and five additional experts. No corporate funding or remuneration was received. The authors agreed to survey relevant databases, journal articles and utilize their own clinical experience. Consensus was guided by systematic discussions by e-mail communications. MAIN OUTCOME/
RESULTS: There is a clear lack of epidemiological data defining female GSP disorders and a lack of evidence supporting therapeutic interventions. However, this international expert group will recommend guidelines for management of female GSP.
CONCLUSIONS: GSP disorders are complex. It is recommended that their evaluation and treatment are performed through comprehensive somato-psychological multidisciplinary approach.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22970822     DOI: 10.1111/j.1743-6109.2012.02867.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  11 in total

1.  Correlation between premature ejaculation and female vaginal penetration difficulties.

Authors:  G Bronner; N D Kitrey; N Uziel; I Eli; G Raviv; J Ramon; E Elran
Journal:  Int J Impot Res       Date:  2015-02-26       Impact factor: 2.896

2.  Superficial dyspareunia.

Authors:  Kinshuk Kumar; Deborah Robertson
Journal:  CMAJ       Date:  2017-06-19       Impact factor: 8.262

3.  Examining the relationship between uterine fibroids and dyspareunia among premenopausal women in the United States.

Authors:  Malana Moshesh; Andrew F Olshan; Tina Saldana; Donna Baird
Journal:  J Sex Med       Date:  2014-01-28       Impact factor: 3.802

4.  Interactions between inflammation and female sexual desire and arousal function.

Authors:  Tierney K Lorenz
Journal:  Curr Sex Health Rep       Date:  2019-10-28

5.  Is psychosexual therapy a reliable alternative to bupropion extended-release to promote the sexual function in infertile women? An RCT.

Authors:  Hajar Pasha; Zahra Basirat; Mahbobeh Faramarzi; Farzan Kheirkhah
Journal:  Int J Reprod Biomed       Date:  2020-03-29

Review 6.  New Insights about Chronic Pelvic Pain Syndrome (CPPS).

Authors:  Keren Grinberg; Yael Sela; Rachel Nissanholtz-Gannot
Journal:  Int J Environ Res Public Health       Date:  2020-04-26       Impact factor: 3.390

7.  Psychiatric disorders in female psychosexual disorders-a nationwide, cohort study in Taiwan : Psychiatric disorders and female psychosexual disorders.

Authors:  Iau-Jin Lin; Nian-Sheng Tzeng; Chi-Hsiang Chung; Wu-Chien Chien
Journal:  BMC Psychiatry       Date:  2021-01-28       Impact factor: 3.630

8.  Differentiating overlapping symptoms of vulvodynia and pudendal neuralgia.

Authors:  Anna Ghizzani; Serafino Carta; Annalisa Casoni; Paolo Ferrata; Stefano Luisi; Mattia Fortina
Journal:  Br J Pain       Date:  2018-05-15

Review 9.  Female reproductive tract pain: targets, challenges, and outcomes.

Authors:  Phillip Jobling; Kate O'Hara; Susan Hua
Journal:  Front Pharmacol       Date:  2014-02-13       Impact factor: 5.810

10.  Treatment of Provoked Vulvodynia in a Swedish cohort using desensitization exercises and cognitive behavioral therapy.

Authors:  Suzanne Lindström; Linda J Kvist
Journal:  BMC Womens Health       Date:  2015-11-25       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.